1. Home
  2. BCRX vs DCO Comparison

BCRX vs DCO Comparison

Compare BCRX & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • DCO
  • Stock Information
  • Founded
  • BCRX 1986
  • DCO 1849
  • Country
  • BCRX United States
  • DCO United States
  • Employees
  • BCRX N/A
  • DCO N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • DCO Military/Government/Technical
  • Sector
  • BCRX Health Care
  • DCO Industrials
  • Exchange
  • BCRX Nasdaq
  • DCO Nasdaq
  • Market Cap
  • BCRX 1.4B
  • DCO 1.4B
  • IPO Year
  • BCRX 1994
  • DCO N/A
  • Fundamental
  • Price
  • BCRX $7.12
  • DCO $91.43
  • Analyst Decision
  • BCRX Strong Buy
  • DCO Strong Buy
  • Analyst Count
  • BCRX 11
  • DCO 4
  • Target Price
  • BCRX $19.00
  • DCO $119.75
  • AVG Volume (30 Days)
  • BCRX 4.8M
  • DCO 117.2K
  • Earning Date
  • BCRX 11-03-2025
  • DCO 11-06-2025
  • Dividend Yield
  • BCRX N/A
  • DCO N/A
  • EPS Growth
  • BCRX N/A
  • DCO N/A
  • EPS
  • BCRX N/A
  • DCO N/A
  • Revenue
  • BCRX $599,816,000.00
  • DCO $806,224,000.00
  • Revenue This Year
  • BCRX $41.57
  • DCO $6.20
  • Revenue Next Year
  • BCRX $6.25
  • DCO $8.26
  • P/E Ratio
  • BCRX N/A
  • DCO N/A
  • Revenue Growth
  • BCRX 45.38
  • DCO 3.17
  • 52 Week Low
  • BCRX $6.00
  • DCO $51.76
  • 52 Week High
  • BCRX $11.31
  • DCO $101.47
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 51.36
  • DCO 50.00
  • Support Level
  • BCRX $6.71
  • DCO $84.76
  • Resistance Level
  • BCRX $7.17
  • DCO $91.35
  • Average True Range (ATR)
  • BCRX 0.26
  • DCO 3.33
  • MACD
  • BCRX 0.01
  • DCO -0.13
  • Stochastic Oscillator
  • BCRX 67.42
  • DCO 43.54

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: